Multiprofile Clinic Consilium Medulla

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer2 trials
• Lung cancer2 trials
• Migraine2 trials
• Triple-negative breast cancer2 trials
• Colorectal cancer1 trial
• Cushing's syndrome1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Metastatic breast cancer1 trial
• Myasthenia gravis1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 11 trial
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• H. Lundbeck A/S3 trials
• Regeneron Pharmaceuticals2 trials
• BioNTech SE1 trial
• IDEAYA Biosciences1 trial
• Karyopharm Therapeutics Inc1 trial

Running trials

• Recruiting

  A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  NCT07503808· Phase 1· IDEAYA Biosciences· Source

  Contact: Elene Dolmazashvili

• Recruiting

  ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  NCT07173751· Phase 3· BioNTech SE· Source

• Active, not recruiting

  A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

  NCT06161441· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

  NCT06471829· Phase 2· H. Lundbeck A/S· Source

• Active, not recruiting

  Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

  NCT05611931· Phase 3· Karyopharm Therapeutics Inc· Source

• Active, not recruiting

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· Phase 3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Triple-negative breast cancer2 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

  NCT05452239· Phase 4· H. Lundbeck A/S· Source

• Completed

  Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine

  NCT04921384· Phase 3· H. Lundbeck A/S· Source